# Are Bleeding Events Valid as a Surrogate Endpoint for Mortality in Cardiovascular Clinical Trials?

**Authors:** Seng Chan You

PMC · DOI: 10.1016/j.jacadv.2023.100335 · JACC: Advances · 2023-05-26

## Full-text entities

- **Diseases:** Bleeding Events (MESH:D002318), Mortality (MESH:D003643)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11198093/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11198093/full.md

## References

19 references — full list in the complete paper: https://tomesphere.com/paper/PMC11198093/full.md

---
Source: https://tomesphere.com/paper/PMC11198093